Squarepoint’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,164,943
| Closed | -$9.62M | – | 3358 |
|
|
2024
Q4 | $9.62M | Buy |
3,164,943
+855,281
| +37% | +$2.6M | 0.01% | 554 |
|
|
2024
Q3 | $12M | Buy |
+2,309,662
| New | +$12M | 0.02% | 444 |
|
|
2023
Q3 | – | Sell |
-32,206
| Closed | -$815K | – | 2963 |
|
|
2023
Q2 | $815K | Sell |
32,206
-57,023
| -64% | -$1.44M | ﹤0.01% | 1377 |
|
|
2023
Q1 | $2.87M | Buy |
89,229
+3,168
| +4% | +$102K | 0.01% | 692 |
|
|
2022
Q4 | $1.59M | Buy |
86,061
+67,310
| +359% | +$1.24M | 0.01% | 873 |
|
|
2022
Q3 | $506K | Sell |
18,751
-15,253
| -45% | -$412K | ﹤0.01% | 1405 |
|
|
2022
Q2 | $470K | Buy |
34,004
+357
| +1% | +$4.93K | ﹤0.01% | 1391 |
|
|
2022
Q1 | $656K | Buy |
+33,647
| New | +$656K | ﹤0.01% | 1363 |
|
|
2021
Q3 | – | Sell |
-30,463
| Closed | -$903K | – | 2851 |
|
|
2021
Q2 | $903K | Buy |
30,463
+20,396
| +203% | +$605K | ﹤0.01% | 1244 |
|
|
2021
Q1 | $281K | Buy |
+10,067
| New | +$281K | ﹤0.01% | 1932 |
|
|
2020
Q4 | – | Sell |
-23,946
| Closed | -$602K | – | 2946 |
|
|
2020
Q3 | $602K | Sell |
23,946
-34,423
| -59% | -$865K | 0.01% | 1217 |
|
|
2020
Q2 | $1.43M | Buy |
58,369
+29,103
| +99% | +$711K | 0.02% | 765 |
|
|
2020
Q1 | $433K | Sell |
29,266
-14,074
| -32% | -$208K | 0.01% | 1115 |
|
|
2019
Q4 | $703K | Buy |
+43,340
| New | +$703K | ﹤0.01% | 1527 |
|
|
2019
Q3 | – | Sell |
-67,528
| Closed | -$876K | – | 2609 |
|
|
2019
Q2 | $876K | Buy |
67,528
+40,082
| +146% | +$520K | 0.01% | 1318 |
|
|
2019
Q1 | $433K | Buy |
27,446
+14,799
| +117% | +$233K | ﹤0.01% | 1537 |
|
|
2018
Q4 | $255K | Sell |
12,647
-5,221
| -29% | -$105K | ﹤0.01% | 1559 |
|
|
2018
Q3 | $444K | Buy |
+17,868
| New | +$444K | 0.01% | 1353 |
|
|
2018
Q2 | – | Sell |
-17,130
| Closed | -$528K | – | 2105 |
|
|
2018
Q1 | $528K | Sell |
17,130
-15,061
| -47% | -$464K | 0.01% | 1070 |
|
|
2017
Q4 | $1.15M | Buy |
+32,191
| New | +$1.15M | 0.02% | 762 |
|